Vincent Yeh

Director Of Program Management at Galvanize Therapeutics, Inc.

Vincent Yeh has a strong background in the biomedical industry, with experience in project management, engineering, and research and development. Vincent is currently working as a Senior Program Manager at Galvanize Therapeutics, Inc. since February 2022. Prior to this, they worked at PROCEPT BioRobotics from September 2017 to January 2022, where they held the positions of Senior R&D Project Manager and R&D Project Manager. Vincent also served as a Fellow at Life Science Angels from July 2017 to January 2019. Earlier in their career, Vincent worked as a Senior R&D Engineer at Avinger Inc. from June 2016 to September 2017. Vincent gained valuable experience as a Senior R&D Engineer at Endologix Inc. from March 2011 to June 2016, where they led the redesign of the Nellix Console and was responsible for drafting CAD files and technical drawings. Vincent started their career as a Staff Engineer at MiCardia Corporation from June 2008 to March 2011, working on device design and testing. Vincent also had internships at Arbor Surgical Technologies and National Taiwan Ocean University.

Vincent Yeh completed their B.S. in Biomedical Engineering from UC Irvine between 2004 and 2008. During the same period, they also pursued a minor in Management from the University of California, Irvine - The Paul Merage School of Business. Later on, from 2019 to 2022, Vincent pursued a Master of Business Administration (MBA) degree from the University of California, Berkeley, Haas School of Business.

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Galvanize Therapeutics, Inc.

1 followers

Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitissymptoms, cardiac arrhythmias, and solid tumors.It was formed by Apple Tree Partners in 2022.


Employees

51-200

Links